PETER CECCHINI

Director of Research

Axonic Capital

Peter Cecchinin is Cantor's Global Chief Market Strategist as well as Head of Cross Asset Strategy. He currently co-chairs Cantor’s internal markets committee consisting of the firm’s business heads. Previously, he served as Cantor's interim Co-Head of Equities. Formerly, he was Chief Strategist and Head of Special Situations at BGC Partners, a Cantor affiliate. Prior to joining BGC and for over three years, Peter was a Partner and Portfolio Manager at Seven Bridges Management, LP. Seven Bridges was an event-driven, special situations hedge fund seeded by Ulysses Management (the successor to Odyssey partners). The fund took long and short positions throughout companies’ capital structures and invested selectively based on a macro-thematic approach. Prior to Seven Bridges, Peter spent four years at BNY Mellon's predecessor, Mellon Financial Corporation (within its Mellon HBV Alternative Strategies, LLC subsidiary and most recently as a Managing Director and group head of distressed investing). There, he directed securities selection, portfolio construction and portfolio hedging. Until its acquisition by Mellon Financial, he spent three years as an analyst and senior analyst at HBV Capital Management. From 2005 through 2007 and upon its emergence from bankruptcy, he sat on the Board of Directors of a North American integrated aluminum producer. Peter has served on numerous equity, unsecured, secured and bank steering committees. Of note, he chaired the equity committee of Impath Corporation, and he helped engineer the sale of the company to Genzyme. Before joining HBV, he spent several years as a consultant at a firm he co-owned. Peter speaks routinely at conferences and appears regularly on various media outlets. He is also a regular contributor to Ben Hunt's Epsilon Theory.Peter holds an MBA from Columbia University (Dean's List), a JD from Boston University School of Law (American Jurisprudence Scholar) and a BA from Haverford College (in Economics). He is an inactive Member of the NY State Bar. His teams work on strategy and quantitative analysis has received All-American Institutional Investor votes in each year since 2012.